A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in ...

Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...

A new study published in the Journal of Internal Medicine showed that it may be possible to prevent the formation of ...

Bacillus Calmette-Guérin (BCG) vaccine -- named for its developers -- contains inactivated mycobacteria that infect cattle and remains the only vaccination strategy against the infection in humans.